Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

DARTMOUTH-HITCHCOCK MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1983-01-01

Employees: 10K

Market Cap: -

Website: http://www.dartmouth-hitchcock.org

Clinical Trials

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

Phase 4

Completed

Conditions: Schizophrenia
Psychotic Disorders
Substance Abuse
Alcohol Abuse

Interventions: Drug: Risperidone Long Acting
Drug: oral risperidone

First Posted Date: 2005-08-16

Last Posted Date: 2019-05-09

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 95

Registration Number: NCT00130923

Locations: 🇺🇸
JMH Mental Health Center, University of Miami, Miami, Florida, United States
🇺🇸
School of Pharmacy, Univ. of Missouri Kansas City, Kansas City, Missouri, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

and more 5 locations

Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes

Completed

Conditions: Pain

First Posted Date: 2005-08-15

Last Posted Date: 2012-02-01

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 20

Registration Number: NCT00130130

Locations: 🇺🇸
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States

Transfusion Medicine - Prevention of Bedside Errors

Not Applicable

Completed

Conditions: Blood Transfusion

First Posted Date: 2005-08-08

Last Posted Date: 2008-05-09

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 300

Registration Number: NCT00127556

Locations: 🇺🇸
LA County and USC Medical Centre, Los Angeles, California, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Centre, Boston, Massachusetts, United States

and more 9 locations

Study of Tarceva and Targretin in Stage I-II Lung Cancer

Not Applicable

Completed

Conditions: Carcinoma, Non-small-cell Lung

Interventions: Drug: erlotinib (Tarceva) and bexarotene (Targretin)

First Posted Date: 2005-08-01

Last Posted Date: 2019-01-08

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 12

Registration Number: NCT00125372

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia

Phase 1

Completed

Conditions: Leukemia

First Posted Date: 2004-08-12

Last Posted Date: 2018-03-19

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 29

Registration Number: NCT00003003

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 1

Completed

Conditions: Melanoma (Skin)

First Posted Date: 2004-06-11

Last Posted Date: 2015-02-02

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Registration Number: NCT00085488

Locations: 🇺🇸
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC

Phase 2

Completed

Conditions: Kidney Cancer

Interventions: Biological: Aldesleukin,
Biological: autologous tumor cell vaccine
Biological: recombinant interferon alfa

First Posted Date: 2004-06-11

Last Posted Date: 2018-06-26

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 18

Registration Number: NCT00085436

Locations: 🇺🇸
Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center, Lebanon, New Hampshire, United States

Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Phase 2

Completed

Conditions: Melanoma (Skin)

Interventions: Biological: aldesleukin
Biological: sargramostim
Drug: cyclophosphamide
Drug: fludarabine phosphate

First Posted Date: 2004-06-11

Last Posted Date: 2013-04-10

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 20

Registration Number: NCT00085423

Locations: 🇺🇸
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer

Phase 1

Terminated

Conditions: Lung Cancer

Interventions: Biological: lepirudin

First Posted Date: 2004-05-03

Last Posted Date: 2016-08-08

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 1

Registration Number: NCT00003726

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: gefitinib
Drug: tamoxifen citrate
Drug: Placebo

First Posted Date: 2004-04-08

Last Posted Date: 2009-08-06

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 2

Registration Number: NCT00080743

Locations: 🇺🇸
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy